HSIC

81.47

0.54% -0.44

Dopo l'orario di chiusura: 81.47

Henry Schein Inc (HSIC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$81.91

Aprire:

$81.58

Volume 24 ore:

2.22M

Relative Volume:

1.69

Capitalizzazione di mercato:

$9.59B

Reddito:

$12.50B

Utile/perdita netta:

$314.00M

Rapporto P/E:

33.39

EPS:

2.44

Flusso di cassa netto:

$421.00M

1 W Prestazione:

+6.08%

1M Prestazione:

+5.00%

6M Prestazione:

+17.97%

1 anno Prestazione:

+12.30%

Intervallo 1D:

$80.25

$82.45

Intervallo di 1 settimana:

$76.17

$89.29

Portata 52W:

$60.56

$89.29

Henry Schein Inc Stock (HSIC) Company Profile

Nome

Henry Schein Inc

Settore

Healthcare (1110)

Industria

Medical Distribution (12)

Telefono

(631) 843-5500

Indirizzo

135 DURYEA RD, MELVILLE, NY

Dipendente

25,000

Cinguettio

@henryschein

Prossima data di guadagno

2026-02-24

Ultimi documenti SEC

HSIC's Discussions on Twitter

Compare HSIC vs MCK, COR, CAH, AHG

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
HSIC Henry Schein Inc	81.47	9.64B	12.50B	314.00M	421.00M	2.44
MCK Mckesson Corporation	974.45	117.98B	397.96B	4.55B	9.64B	34.77
COR Cencora Inc	366.65	70.62B	325.78B	1.64B	3.61B	8.3139
CAH Cardinal Health Inc	227.13	53.22B	244.67B	1.68B	5.51B	6.9487
AHG Akso Health Group Adr	1.40	1.10B	2.22M	-5.63M	-1.68M	-0.24

Henry Schein Inc Stock (HSIC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-09	Iniziato	Barclays	Overweight
2025-08-26	Aggiornamento	Evercore ISI	In-line → Outperform
2025-07-25	Downgrade	Stifel	Buy → Hold
2025-07-14	Downgrade	Robert W. Baird	Outperform → Neutral
2025-02-14	Iniziato	Wells Fargo	Equal Weight
2025-01-06	Aggiornamento	BofA Securities	Underperform → Buy
2024-12-04	Iniziato	Mizuho	Neutral
2024-07-22	Aggiornamento	Robert W. Baird	Neutral → Outperform
2024-02-26	Iniziato	Leerink Partners	Market Perform
2023-12-12	Aggiornamento	JP Morgan	Neutral → Overweight
2023-11-10	Aggiornamento	Stifel	Hold → Buy
2022-08-08	Aggiornamento	UBS	Sell → Neutral
2022-07-21	Downgrade	Goldman	Buy → Neutral
2022-06-14	Downgrade	Robert W. Baird	Outperform → Neutral
2022-05-13	Ripresa	Credit Suisse	Outperform
2022-01-31	Iniziato	Morgan Stanley	Underweight
2022-01-07	Aggiornamento	Credit Suisse	Neutral → Outperform
2021-10-01	Ripresa	Credit Suisse	Neutral
2021-02-08	Ripresa	Piper Sandler	Overweight
2021-01-04	Aggiornamento	Robert W. Baird	Neutral → Outperform
2020-11-03	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2020-05-06	Downgrade	Barrington Research	Outperform → Mkt Perform
2020-04-07	Aggiornamento	Goldman	Neutral → Buy
2020-04-02	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2020-01-09	Downgrade	BofA/Merrill	Neutral → Underperform
2020-01-02	Aggiornamento	Evercore ISI	Underperform → In-line
2019-08-07	Downgrade	William Blair	Outperform → Mkt Perform
2019-05-30	Iniziato	Wolfe Research	Underperform
2019-05-15	Downgrade	SVB Leerink	Outperform → Mkt Perform
2019-04-18	Iniziato	Guggenheim	Buy
2019-01-17	Iniziato	UBS	Sell
2019-01-03	Downgrade	Evercore ISI	In-line → Underperform
2019-01-02	Downgrade	Robert W. Baird	Outperform → Neutral
2018-11-08	Reiterato	Barrington Research	Outperform
2018-10-25	Downgrade	Edward Jones	Hold → Sell
2018-10-19	Ripresa	Goldman	Neutral
2018-10-04	Reiterato	Robert W. Baird	Outperform
2018-08-07	Reiterato	Stifel	Hold
2018-04-24	Downgrade	Goldman	Buy → Neutral
2018-04-04	Aggiornamento	Leerink Partners	Mkt Perform → Outperform

Mostra tutto

Henry Schein Inc Borsa (HSIC) Ultime notizie

Feb 25, 2026

Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Henry Schein (HSIC) - The Globe and Mail

Feb 25, 2026

Henry Schein (HSIC): UBS Maintains "Neutral" Rating, Price Targe - GuruFocus

Feb 25, 2026

Henry Schein Reports Strong Q4 Earnings Exceeding Expectations - Intellectia AI

Feb 25, 2026

These Analysts Increase Their Forecasts On Henry Schein After Upbeat Q4 Results - Benzinga

Feb 25, 2026

Research Alert: CFRA Maintains Sell Rating On Shares Of Henry Schein Inc. - 富途牛牛

Feb 25, 2026

Barrington Adjusts Price Target on Henry Schein to $97 From $79, Maintains Outperform Rating - marketscreener.com

Feb 25, 2026

UBS Adjusts Price Target on Henry Schein to $87 From $79, Maintains Neutral Rating - marketscreener.com

Feb 25, 2026

Evercore ISI Adjusts Price Target on Henry Schein to $100 From $90 - marketscreener.com

Feb 25, 2026

Baird Adjusts Price Target on Henry Schein to $104 From $100 - marketscreener.com

Feb 25, 2026

Leerink Partners Adjusts Price Target on Henry Schein to $87 From $75 - marketscreener.com

Feb 25, 2026

Henry Schein, Inc. (NASDAQ:HSIC) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 25, 2026

Stifel Adjusts Price Target on Henry Schein to $84 From $72 - marketscreener.com

Feb 25, 2026

Analysts Conflicted on These Healthcare Names: Henry Schein (HSIC), Delcath Systems (DCTH) and Certara (CERT) - The Globe and Mail

Feb 25, 2026

Decoding Henry Schein Inc (HSIC): A Strategic SWOT Insight - GuruFocus

Feb 25, 2026

Feb 24, 2026

Henry Schein Balances Strong Growth With Margin Pressure - TipRanks

Feb 24, 2026

Henry Schein (HSIC) Margin Stays Near 3% And Tests Premium P/E Narrative - simplywall.st

Feb 24, 2026

Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch

Feb 24, 2026

Analyst Expectations For Henry Schein's Future - Benzinga

Feb 24, 2026

Henry Schein stock hits 52-week high at 83.92 USD By Investing.com - Investing.com South Africa

Feb 24, 2026

Henry Schein (HSIC) Stock Trades Up, Here Is Why - Finviz

Feb 24, 2026

Henry Schein Q4 2025 slides: strongest sales growth in 15 quarters - Investing.com Canada

Feb 24, 2026

Henry Schein Reports Growth in Dental and Specialty Product Sales for 2025 - Orthodontic Products

Feb 24, 2026

Piper Sandler Raises Henry Schein Price Target to $99 From $83 - marketscreener.com

Feb 24, 2026

Leerink Partners Raises Henry Schein Price Target to $87 From $75 - marketscreener.com

Feb 24, 2026